Deepa K Ingawale Selected Research

hecogenin

4/2021	Hecogenin and fluticasone combination attenuates TNBS-induced ulcerative colitis in rats via downregulation of pro-inflammatory mediators and oxidative stress.
4/2019	Anti-inflammatory potential of hecogenin on atopic dermatitis and airway hyper-responsiveness by regulation of pro-inflammatory cytokines.
2/2018	Hecogenin exhibits anti-arthritic activity in rats through suppression of pro-inflammatory cytokines in Complete Freund's adjuvant-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepa K Ingawale Research Topics

Disease

3	Inflammation (Inflammations) 04/2020 - 03/2015
2	Neoplasms (Cancer) 05/2021 - 04/2019
2	Asthma (Bronchial Asthma) 04/2020 - 04/2019
1	Ulcerative Colitis 04/2021
1	Colitis 04/2021
1	Respiratory Hypersensitivity 04/2019
1	Erythema 04/2019
1	Atopic Dermatitis (Atopic Eczema) 04/2019
1	Skin Diseases (Skin Disease) 04/2019
1	Arthritis (Polyarthritis) 02/2018
1	Rheumatoid Arthritis 02/2018
1	Edema (Dropsy) 02/2018
1	Hypoxia (Hypoxemia) 03/2015
1	Necrosis 01/2014
1	Alcoholism (Alcohol Abuse) 01/2014

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 04/2020 - 01/2014
3	hecogeninIBA 04/2021 - 02/2018
3	Fluticasone (Cutivate)FDA LinkGeneric 04/2021 - 04/2019
2	OvalbuminIBA 04/2020 - 04/2019
2	EnzymesIBA 03/2015 - 01/2014
1	Sulfonic AcidsIBA 04/2021
1	sarsasapogeninIBA 04/2020
1	Pharmaceutical PreparationsIBA 04/2020
1	Freund's AdjuvantIBA 02/2018
1	Arachidonic Acid (Vitamin F)IBA 03/2015
1	ChemokinesIBA 03/2015
1	Platelet Activating FactorIBA 03/2015
1	AllergensIBA 03/2015
1	Peptides (Polypeptides)IBA 03/2015
1	GalactosamineIBA 01/2014
1	GasesIBA 01/2014
1	Chlorinated HydrocarbonsIBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014
1	Biological ProductsIBA 01/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2014
1	LigandsIBA 01/2014
1	LipopolysaccharidesIBA 01/2014
1	MycotoxinsIBA 01/2014
1	BCG Vaccine FDA Link 01/2014
1	Azathioprine (Imuran)FDA LinkGeneric 01/2014
1	ArsenicIBA 01/2014
1	AntioxidantsIBA 01/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2014
1	Analgesics (Analgesic Drugs)IBA 01/2014
1	Thioacetamide (Thioacetamid)IBA 01/2014
1	XenobioticsIBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014
1	Heavy MetalsIBA 01/2014
1	JNK Mitogen-Activated Protein KinasesIBA 01/2014
1	AflatoxinsIBA 01/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 01/2014
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2014
1	Free RadicalsIBA 01/2014
1	CadmiumIBA 01/2014

Therapy/Procedure

1	Immunomodulation 05/2021
1	Rejuvenation 05/2021
1	Catheters 04/2021
1	Rectal Administration 04/2021
1	Drug Therapy (Chemotherapy) 04/2020
1	Intranasal Administration 04/2019
1	Therapeutics 04/2019